DIMENSIONAL FUND ADVISORS LP
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 354204
AUSTIN, TX
Position in ARWR
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$96,312,866
+$58,157,974 QoQ
Shares Held
1,181,608
+94.2% QoQ
Ownership
0.837%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#19
of 497 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 82%
Shared 9%
None 9%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,105,781,867 across 230 Biotechnology names. ARWR ranks #17 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in ARWR
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $96,312,866 | 1,181,608 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $38,154,892 | 608,531 | Shares | Defined | 2026-05-07 | |
| 2025-12-31 | $9,786,682 | 147,412 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $16,364,193 | 474,462 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $5,794,033 | 366,711 | Shares | Sole | 2025-08-12 | |
| 2024-12-31 | $670,520 | 35,666 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,360,815 | 121,880 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $3,791,265 | 145,874 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,744,800 | 61,007 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $16,762,250 | 547,786 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $18,484,166 | 687,911 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $12,637,723 | 354,395 | Shares | Sole | 2023-08-09 | |
| 2022-12-31 | $679,745 | 16,759 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $553,884 | 16,759 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,230,343 | 34,943 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,677,491 | 58,219 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $8,041,460 | 121,289 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $9,869,558 | 158,090 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $18,186,278 | 219,588 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $14,129,069 | 213,076 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $17,824,379 | 232,300 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $14,124,325 | 328,015 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $12,873,125 | 298,058 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $3,948,193 | 137,233 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||